PharmaResources (Shanghai) Co., Ltd. (SZSE: 301230)
Health Care · Life Sciences Tools & Services · CN
CN¥38.48
+0.79% today · +45.5% 1Y
PharmaResources (Shanghai) Co., Ltd. (SZSE: 301230) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $1.03B.
Over the last twelve months the share price has gained 45.5%, trading between 22.23 and 52.28.
Tweenvest scores PharmaResources (Shanghai) Co., Ltd. across four factors: quality 70/100, value 9/100, growth 54/100, dividend 48/100. Its strongest factor is quality.
301230 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.03B
- Revenue (TTM)
- $103.05M
- P/E
- 188.19
- EPS
- 0.20
- Dividend yield
- 0.74%
- Beta (5Y)
- 0.88
- 52-week high
- CN¥52.28
- 52-week low
- CN¥22.23
- Avg volume (3M)
- —
- Shares outstanding
- 179.20M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Novogene Co., Ltd.SHSE: 688315 | $1.19B | CN¥19.77 | -3.09% |
| Maravai LifeSciences Holdings, Inc.NasdaqGS: MRVI | $1.18B | $7.40 | -6.33% |
| Beijing Sun-Novo Pharmaceutical Research Co., Ltd.SHSE: 688621 | $1.16B | CN¥71.00 | -2.41% |
| Gerresheimer AGXTRA: GXI | $1.12B | €29.06 | +0.21% |
| Anhui Wanbang Pharmaceutical Technology Co.,Ltd.SZSE: 301520 | $982.60M | CN¥71.05 | -4.23% |
| R&G PharmaStudies Co., Ltd.SZSE: 301333 | $952.14M | CN¥66.67 | +3.70% |
| Suven Life Sciences LimitedBSE: 530239 | $905.38M | Rs308.50 | -7.90% |
| Shanghai Runda Medical Technology Co., Ltd.SHSE: 603108 | $898.64M | CN¥9.97 | -0.10% |
Figures last refreshed Oct 4, 2026.